Results 101 to 110 of about 40,229 (203)
ObjectiveThis study aimed to evaluate the real-world clinical efficacy and safety of cefepime in treating pediatric community-acquired pneumonia (CAP), comparing it with other broad-spectrum antibiotics, including cefoperazone-sulbactam and meropenem ...
Changxin Liu +6 more
doaj +1 more source
Introduction: Cefepime/enmetazobactam is a novel β-lactam/β-lactamase inhibitor (BL-BLI) combination with broad Gram-positive and -negative activity. Cefepime is relatively resistant to hydrolysis by AmpC, and enmetazobactam inhibits all Ambler Class A ...
Dubey, Vineet +2 more
core +1 more source
FIC values of Ampicillin/sulbactam plus Cefepime combination.
FIC values of Ampicillin/sulbactam plus Cefepime combination.
Mona M. Abdelkader (3753058) +3 more
core +1 more source
The Enterobacter cloacae complex (ECC) comprises multiple species that require genomic analysis for precise identification. They produce inducible AmpC β-lactamase and may carry acquired β-lactamases, which are responsible for cefotaxime and cefepime ...
Akihiko Matsuo +5 more
doaj +1 more source
Cefepime is active against bacteria producing chromosomally and plasmid-mediated extended broad-spectrum β-lactamase enzymes. The aim of this study was to evaluate risk factors for acquisition of cefepime resistance in <i>Escherichia coli </i>
Parisa Norabadi +2 more
core +1 more source
Antibiotic restriction can be useful in maintaining bacterial susceptibility. The objective of this study was verify if restriction of cefepime, the most frequently used cephalosporin in our neonatal intensive care unit (NICU), would ameliorate broad ...
Orlei Ribeiro de Araujo +7 more
doaj +1 more source
Background: Levofloxacin and tobramycin, alone and in combination with cefepime, were investigated for their in vitro activities and post-antibiotic effects (PAEs) on Pseudomonas aeruginosa. Methods: The in vitro activities of tobramycin and levofloxacin
Ozbek, Berna +3 more
core +1 more source
Rapid detection of cefepime-taniborbactam susceptibility/resistance in Enterobacterales
Objective: Metallo-β-lactamase-producing Enterobacterales is widely distributed and confers resistance to all β-lactams, including carbapenems. Recently, a cefepime-taniborbactam combination has been developed that aims to provide a treatment option ...
Le Terrier, Christophe +4 more
core +1 more source
Farmacocinética de Cefepime en pacientes con neoplasias hematológicas y neutropenia febril post-quimioterapia en el Instituto Nacional de Cancerología, empresa social del estado, Bogotá [PDF]
Este estudio abierto, no aleatorizado, observacional, descriptivo, prospectivo evalúa los parámetros PK de cefepime en pacientes con neoplasias hematológicas y NFPQ en el INC, consta de dos fases: La primera, 15 pacientes con neoplasia hematológica, sin ...
Álvarez Rodríguez, José Camilo
core
The safety of cefepime in the treatment of infection
Cefepime is a fourth-generation cephalosporin usually reserved for treating severe nosocomial pneumonia, as well as empirical treatment of febrile neutropenia, uncomplicated and complicated urinary tract infections, uncomplicated skin and skin structure ...
E. De Vecchi, L. Drago
core +1 more source

